Danaher Management

Management Kriterienprüfungen 3/4

Danaher CEO ist Rainer Blair , ernannt in Sep 2020, hat eine Amtszeit von 4.17 Jahren. Die jährliche Gesamtvergütung beträgt $20.90M , bestehend aus 6.2% Gehalt und 93.8% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.014% der Aktien des Unternehmens, im Wert von $24.51M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 5.8 Jahre bzw. 14.5 Jahre.

Wichtige Informationen

Rainer Blair

Geschäftsführender

US$20.9m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts6.2%
Amtszeit als Geschäftsführer4.2yrs
Eigentum des Geschäftsführers0.01%
Durchschnittliche Amtszeit des Managements5.8yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder14.5yrs

Jüngste Management Updates

Recent updates

Understanding Danaher's Cautiousness

Oct 25

Is There Now An Opportunity In Danaher Corporation (NYSE:DHR)?

Sep 28
Is There Now An Opportunity In Danaher Corporation (NYSE:DHR)?

Danaher Q3 Preview: Market Share Gains In Molecular Testing

Sep 25

Is Danaher Corporation (NYSE:DHR) Trading At A 32% Discount?

Sep 12
Is Danaher Corporation (NYSE:DHR) Trading At A 32% Discount?

Here's Why Danaher (NYSE:DHR) Can Manage Its Debt Responsibly

Aug 28
Here's Why Danaher (NYSE:DHR) Can Manage Its Debt Responsibly

Danaher: Lofty Price, Bright Future

Aug 22

Danaher Corporation's (NYSE:DHR) Price In Tune With Earnings

Aug 13
Danaher Corporation's (NYSE:DHR) Price In Tune With Earnings

Danaher: Valuation Now Too High Even Compared To Own High Standards

Jul 16

What Is Danaher Corporation's (NYSE:DHR) Share Price Doing?

Jun 23
What Is Danaher Corporation's (NYSE:DHR) Share Price Doing?

Mar Vista - Danaher: Headwinds Are Primarily Cyclical, Growth To Regain Momentum

Jun 20

Is Danaher Corporation (NYSE:DHR) Worth US$263 Based On Its Intrinsic Value?

Jun 05
Is Danaher Corporation (NYSE:DHR) Worth US$263 Based On Its Intrinsic Value?

Is Danaher (NYSE:DHR) A Risky Investment?

May 21
Is Danaher (NYSE:DHR) A Risky Investment?

It's Unlikely That Danaher Corporation's (NYSE:DHR) CEO Will See A Huge Pay Rise This Year

May 01
It's Unlikely That Danaher Corporation's (NYSE:DHR) CEO Will See A Huge Pay Rise This Year

Value Vs. Growth? Danaher Says Why Not Both?

Apr 25

Danaher: All In On Life Sciences, And Market Update

Mar 27

Is Now An Opportune Moment To Examine Danaher Corporation (NYSE:DHR)?

Mar 11
Is Now An Opportune Moment To Examine Danaher Corporation (NYSE:DHR)?

Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings

Feb 10
Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings

Bull Case Confirmed: Danaher Is Still One Of The Best Stocks To Buy Long-Term

Jan 30

Is Danaher (NYSE:DHR) Using Too Much Debt?

Jan 12
Is Danaher (NYSE:DHR) Using Too Much Debt?

My Top 2024 Stock Pick: Danaher

Dec 27

Danaher: Poised For Long-Term Growth Despite Near-Term Hurdles

Nov 26

RGA Investment Advisors - Danaher:  Purity In The Crown Jewel Of Bioprocessing

Nov 19

Why Danaher Is One Of My Favorite Long-Term Investments

Oct 26

Danaher: Short-Term Headwinds, But Long-Term Tailwinds

Oct 17

Should Danaher Investors Sell New Veralto Shares?

Oct 02

Danaher Corporation's (NYSE:DHR) Intrinsic Value Is Potentially 18% Below Its Share Price

Sep 30
Danaher Corporation's (NYSE:DHR) Intrinsic Value Is Potentially 18% Below Its Share Price

Danaher: A Lost Year

Aug 30

Third Point - Danaher: Don't Be Surprised If Growth Rate Moves To Low Teens

Aug 02

Danaher: A Compounding Icon At A Fair Price

Jul 25

These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Reasonably Well

Jul 13
These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Reasonably Well

Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Jun 28
Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Danaher: Seizing The Buying Opportunity In A Temporary Bioprocessing Slump

Jun 22

At US$238, Is It Time To Put Danaher Corporation (NYSE:DHR) On Your Watch List?

Jun 15
At US$238, Is It Time To Put Danaher Corporation (NYSE:DHR) On Your Watch List?

Danaher: A Great Chance To Buy This Long-Term Compounder

May 23

With EPS Growth And More, Danaher (NYSE:DHR) Makes An Interesting Case

Apr 26
With EPS Growth And More, Danaher (NYSE:DHR) Makes An Interesting Case

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Rainer Blair im Vergleich zu den Einnahmen von Danaher verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 27 2024n/an/a

US$4b

Jun 28 2024n/an/a

US$4b

Mar 29 2024n/an/a

US$4b

Dec 31 2023US$21mUS$1m

US$4b

Sep 29 2023n/an/a

US$4b

Jun 30 2023n/an/a

US$5b

Mar 31 2023n/an/a

US$6b

Dec 31 2022US$20mUS$1m

US$6b

Sep 30 2022n/an/a

US$7b

Jul 01 2022n/an/a

US$6b

Apr 01 2022n/an/a

US$6b

Dec 31 2021US$17mUS$1m

US$5b

Oct 01 2021n/an/a

US$6b

Jul 02 2021n/an/a

US$5b

Apr 02 2021n/an/a

US$5b

Dec 31 2020US$10mUS$949k

US$4b

Oct 02 2020n/an/a

US$3b

Jul 03 2020n/an/a

US$3b

Apr 03 2020n/an/a

US$3b

Dec 31 2019US$7mUS$840k

US$2b

Sep 27 2019n/an/a

US$2b

Jun 28 2019n/an/a

US$2b

Mar 29 2019n/an/a

US$2b

Dec 31 2018US$5mUS$700k

US$2b

Sep 28 2018n/an/a

US$3b

Jun 29 2018n/an/a

US$3b

Mar 30 2018n/an/a

US$3b

Dec 31 2017US$4mUS$625k

US$2b

Vergütung im Vergleich zum Markt: RainerDie Gesamtvergütung ($USD20.90M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD12.86M).

Entschädigung vs. Einkommen: RainerDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.


Geschäftsführer

Rainer Blair (60 yo)

4.2yrs

Amtszeit

US$20,903,282

Vergütung

Mr. Rainer M. Blair serves as Director at Nestlé S.A. since April 20, 2023. He serves as President, Chief Executive Officer and Director at Danaher Corporation since September 1, 2020. Mr. Blair served as...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Steven Rales
Co-Founder & Chairman41.8yrskeine Daten6.02%
$ 10.9b
Rainer Blair
President4.2yrsUS$20.90m0.014%
$ 24.5m
Mitchell Rales
Co-Founder & Director41.8yrskeine Daten4.86%
$ 8.8b
Matthew McGrew
CFO & Executive VP5.8yrsUS$7.50m0.0053%
$ 9.6m
Jose-Carlos Gutierrez-Ramos
Senior VP & Chief Science Officer3.9yrsUS$7.20m0.00037%
$ 668.3k
Georgeann Couchara
Senior Vice President of Human Resources2.6yrsUS$5.25m0.00015%
$ 270.9k
Christopher Bouda
VP & Chief Accounting Officer2.8yrskeine Daten0.00081%
$ 1.5m
John Bedford
Vice President of Investor Relationsno datakeine Datenkeine Daten
Brian Ellis
Senior VP8.8yrsUS$3.56m0.0028%
$ 5.1m
Daniel Raskas
Senior Vice President of Corporate Development14.8yrskeine Daten0.0033%
$ 5.9m
William King
Senior Vice President of Strategic Development10.5yrskeine Daten0.0067%
$ 12.0m
Christopher Riley
Executive VP of Biotechnology Group & CEO of Cytivaless than a yearkeine Daten0.0020%
$ 3.6m

5.8yrs

Durchschnittliche Betriebszugehörigkeit

57yo

Durchschnittliches Alter

Erfahrenes Management: DHRDas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (5.8 ).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Steven Rales
Co-Founder & Chairman41.8yrskeine Daten6.02%
$ 10.9b
Rainer Blair
President4.2yrsUS$20.90m0.014%
$ 24.5m
Mitchell Rales
Co-Founder & Director41.8yrskeine Daten4.86%
$ 8.8b
Alan Spoon
Independent Director25.8yrsUS$338.13k0.011%
$ 20.4m
John Schwieters
Independent Director21.3yrsUS$351.13k0.0054%
$ 9.8m
Elias Zerhouni
Independent Director15.8yrsUS$338.13k0.0024%
$ 4.3m
Raymond Stevens
Independent Director7.8yrsUS$318.13k0%
$ 0
Angela Caliendo
Member of Scientific Advisory Board3.6yrskeine Datenkeine Daten
Linda Filler
Lead Independent Director18.9yrsUS$382.13k0.0057%
$ 10.3m
Teri List-Stoll
Independent Director13.2yrsUS$318.13k0%
$ 0
Jessica Mega
Independent Director5yrsUS$318.13k0%
$ 0
Pardis Sabeti
Director5yrsUS$318.13k0%
$ 0

14.5yrs

Durchschnittliche Betriebszugehörigkeit

64yo

Durchschnittliches Alter

Erfahrener Vorstand: DHRDie Vorstandsmitglieder sind sehr erfahren ( 14.5 ).